仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用. Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research